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| INTRODUCTION
Abnormalities of von Willebrand factor (VWF), typically with loss of the highest molecular weight multimers (HMW), have been identified in states of high intravascular shear stress, most often manifesting clinically through a bleeding diathesis. The prototypical description of this phenomenon is Heyde syndrome, the association of severe aortic stenosis (AS) and gastrointestinal bleeding due to angiodysplasia. 1 Though loss of HMW VWF multimers and associated bleeding was first described in AS, recent descriptions of a similar constellation of findings has been associated with a variety of cardiac lesions including aortic regurgitation, mitral insufficiency and hypertrophic cardiomyopathy. [2] [3] [4] Additionally, VWF abnormalities have been described after valve replacement and repair and have been attributed to prosthetic valve dysfunction, perivalvular leak, patient prosthesis mismatch, [5] [6] [7] and in the setting of mechanical support with left ventricular assist devices. 8 More recently, abnormalities of VWF multimers have been identified in the absence of clinical bleeding and studies suggest that VWF multimers may provide utility as a biological assay for cardiac lesions in real-time and chronic settings. 9 Although this emerging data supports the use of VWF multimers for assessment of some cardiac lesions, a pooled cohort of various valvular and non-valvular high-shear cardiac states has not been described. Furthermore, variation exists in the processing and interpretation of VWF multimers between clinical laboratories, potentially limiting the reproducibility of VWF assays and their clinical utility.
We report a diverse cohort of prospectively studied patients with high shear cardiac lesions including aortic stenosis, aortic or mitral regurgitation, normal prosthetic heart valves, dysfunctional prosthetic heart valves, hypertrophic obstructive cardiomyopathy, and left ventricular assist devices in which we assessed the association of VWF multimer abnormalities and the hemodynamic severity of these cardiac lesions as well as bleeding histories. Second, we investigated the use of various normalized VWF multimer ratios (NMR) as a novel assessment of cardiac lesion severity and bleeding risk compared to traditional measures such as VWF antigen to activity ratio and platelet function analyzer-100.
| METHODS
We identified patients with cardiac lesions from our multispecialty practice between 2010 and 2016 as previously described. Patients were asked to complete a bleeding questionnaire (Appendix) modified from the consensus conference on the assessment of von Willebrand disease as previously described. 
Essentials
• VWF multimers have an established association with valvular heart disease.
• Significant interlaboratory variation exists in VWF multimeric analysis.
• We describe a method to normalize VWF multimers for assessment of cardiac lesion severity and clinical bleeding.
• Normalized VWF multimer ratios improved the diagnostic capabilities of the assay.
Qualitative loss of HMW VWF multimers was assessed with in-gel western blot gel electrophoresis 11 and VWF antigen (VWF:ag), VWF latex immunoturbidic activity (VWF:act), and quantitative loss of VWF ratios of multimers >15/2-15 mers and >10/2-10 mers were assessed in patients citrated frozen plasma samples, as previously described. 
| RESULTS AND DISCUSSION
The baseline characteristics of 395 subjects in this cohort that contributed 476 blood specimens are shown in and aspirin (91%) and were the group most likely to report a history of bleeding (60%). Patient characteristics and laboratory findings stratified by cardiac lesion severity are described in Table 2 . The group without cardiac lesions was younger as the majority of these subjects were physicians-in-training that were recruited as a control group for a separate study, otherwise there were no differences in age or sex amongst patients with cardiac lesions. Patients identified as having moderate or severe cardiac lesions reported more bleeding, were more anemic, and had abnormal VWF laboratory profiles (P < .01 for all except VWF activity). The presence of VWF multimer abnormalities demonstrated a linear relationship with cardiac lesion severity (Chi Square = 210, P < .001) (Figure 2A ). Abnormal VWF multimers were not seen in the patients with structurally normal hearts (0%) but were present in mild (21%), moderate (64%), and severe (88%) cardiac lesions. Bleeding status was available for 347 of 476 samples. Patients that reported bleeding were more likely to be female, anemic, and have moderate or severe cardiac lesions (Table 2) . Abnormal VWF multimers were present in 65% of bleeders compared to 46% of non-bleeders.
We explored the diagnostic utility of traditional VWF laboratories and NMR for the identification of moderate to severe cardiac lesions as well as clinically significant bleeding ( (Sensitivity 68% vs 56%), however no particular test was more strongly associated with bleeding than others.
A growing body of data supports the concept that VWF can be regurgitation, allowing for procedural adjustment of TAVR. 9 The PFA- 
